Rhythm Pharmaceuticals (RYTM +7.86%) was a healthcare company perfectly in tune with investor goals on Tuesday. Shares of the commercial-stage biotech soared to close almost 8% higher in value, thanks to a very well-received quarterly earnings report. Imcivree for the win Rhythm, which rose to prominence thanks to its highly specialized weight-loss drug Imcivree, reported

A man looks at a screen showing global stock market information on the street in Tokyo, Japan. Chris McGrath | Getty Images South Korea’s Kospi hit another record Wednesday as Asia-Pacific markets opened higher, tracking Wall Street gains overnight after oil prices dropped and strong earnings lifted investor sentiment. Signaling diplomatic efforts for resolving the

As central banks in major economies hold interest rates steady amid geopolitical uncertainties, the Asian markets are navigating a complex landscape of currency fluctuations and evolving policy expectations. In this environment, identifying stocks that may be priced below their estimated value requires careful consideration of factors such as earnings resilience and sector-specific growth potential. Top